Premium European regenerative medicine in Barcelona using autologous mesenchymal stem cell protocols, exosomes and cellular biotechnology for international patients.

Premium European regenerative medicine in Barcelona using autologous mesenchymal stem cell protocols, exosomes and cellular biotechnology for international patients.
Autologous mesenchymal cells are studied for paracrine signaling, trophic factor release, extracellular vesicle communication, immunomodulation and support of the tissue microenvironment. Many chronic conditions involve inflammation, fibrosis, oxidative stress, mitochondrial stress, impaired microcirculation and dysregulated repair signaling.









The Barcelona pathway begins with medical file review, diagnostic context, previous treatment analysis, risk assessment, contraindication review and definition of realistic objectives. Only after this stage can a personalized protocol be considered.
Carrer de Dos de Maig 301, Barcelona, Spain